EMA Authorised: Ztalmy (ganaxolone) — Marinus Pharmaceuticals Emerald Limited

View source ↗

Summary

The European Medicines Agency authorized Ztalmy (ganaxolone) for infantile epileptic spasms and related epileptic syndromes, marking EU approval for this therap…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epileptic Syndromes
• Infantile Spasms

Drugs mentioned

• ZTALMY (ganaxolone)

Snippet

Status: Authorised. Therapeutic area: Epileptic Syndromes;Spasms, Infantile. MAH: Marinus Pharmaceuticals Emerald Limited. Decision date: 15/01/2026. Orphan medicine